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Abstract. Intestinal graft-vs.-host disease (GVHD) is a serious 
complication of allo-hematopoietic stem cell transplantation 
(allo-HSCT). Villous atrophy in the terminal ileum is considered 
a useful diagnostic indicator for GVHD. However, the inter- and 
intra‑observer agreement regarding the ileocolonoscopic find-
ings indicative of acute intestinal GVHD, i.e., villous atrophy in 
the terminal ileum, are currently insufficient in multiple institu-
tions. Thus, the present study aimed to investigate the incidence 
of villous atrophy in the terminal ileum to diagnose acute 
intestinal GVHD and determine the inter- and intra-observer 
agreement regarding this result for experienced endoscopists 
from multiple institutions. Consecutive patients who underwent 
allo-HSCT were referred to our institution between May 2008 
and September 2015. A total of 54 patients underwent total ileo-
colonoscopy after allo-HSCT due to suspected intestinal acute 
GVHD. Subsequently, three observers from different institutions 
evaluated the cases for the presence of villous atrophy in the 
terminal ileum. In this study, the pathology results were a gold 
standard to evaluate the predictive value of ileocolonoscopy 
detection. Definitive pathological and non‑pathological GVHD 
was diagnosed in 22 and 32 cases, respectively. The results of 
examining whether villous atrophy could predict GVHD were 
as follows. For three observers (A, B and C), the sensitivity of 
villous atrophy in the terminal ileum was 86.4, 77.3 and 79.2%, 
respectively, whereas the specificity was 62.5, 62.5 and 86.7%, 
respectively. The positive predictive value  (PPV) and negative 
predictive value (NPV) of villous atrophy for GVHD were as 
follows: The PPV of appearance was 61.3, 58.6 and 82.6%, 
respectively, whereas the NPV was 87.0, 80.0 and 83.9%, respec-
tively. Kappa coefficients for the inter‑observer reliability were 
0.85, 0.63 and 0.63 for observers A and B, A and C, and B and C, 
respectively. The intra‑observer kappa coefficient was 0.88 for 
observer A, 0.73 for observer B and 0.75 for observer C. A 
substantial observer agreement was achieved for the analysis of 
villous atrophy in the terminal ileum and the agreement for the 
predictive histological diagnosis was also excellent. Based on 
the results of the present study, identification of villous atrophy 
in the terminal ileum was a clinically effective diagnostic 
parameter, even if different endoscopists were involved in the 
diagnosis at multiple institutions. The present study was regis-
tered as a trial with the University Hospital Medical Information 
Network (UMIN; registration no. UMIN000025390).
Introduction
Allo-hematopoietic stem cell transplantation (allo-HSCT) has 
become an essential part of the standard therapeutic manage-
ment for several hematological diseases and malignancies, 
including acute or chronic leukemia. An estimated 10-40% of 
patients who undergo allo‑HSCT develop significant clinical 
acute graft-vs.-host disease (GVHD) (1). Gastrointestinal 
GVHD usually occurs ≥3 weeks after allo‑HSCT and is 
characterized by profuse diarrhea, anorexia, nausea, vomiting, 
abdominal pain and gastrointestinal bleeding (2,3).
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Accurate diagnosis of intestinal GVHD is required, which 
is based on histological findings, including crypt abnormalities, 
e.g. degeneration, dilatation, abscesses and crypt loss, which 
accompany epithelial apoptosis in the ileum and colon (4). 
Ileocolonoscopy is commonly performed, as patients suspected 
to have acute GVHD complain of gastrointestinal symptoms. 
Pathological examination is indispensable for the confirma-
tion of GVHD diagnosis; however, treatment may be rapidly 
initiated after the preliminary endoscopic diagnosis. Previous 
studies have reported that classic endoscopic features, including 
orange-peel appearance, spotty redness, small mucosa 
sloughing and diffuse mucosal defect, are useful in diagnosing 
acute GVHD (5). It has been previously reported that villous 
atrophy of the terminal ileum is most useful for the diagnosis 
of GVHD (6). However, these previous studies did not address 
details of the random sequence and were performed at a single 
institution. Thus, the present study aimed to investigate the 
incidence of villous atrophy in the terminal ileum and the 
inter- and intra-observer agreement for this finding among 
experienced endoscopists in multiple centers.
Materials and methods
Patients. The present retrospective study comprised 261 
consecutive patients who underwent allo-HSCT and were 
referred to the Okayama University Graduate School 
of Medicine (Okayama, Japan) between May 2008 and 
September 2015. Among them, 62 patients underwent colo-
noscopy and had symptoms suggestive of gastrointestinal 
GVHD, including anorexia, nausea, vomiting, watery diar-
rhea and abdominal pain. All patients underwent biopsies in 
each of the following segments regardless of the presence or 
absence of abnormalities that may be indicative of intestinal 
GVHD: Terminal ileum, right hemi-colon, left hemi-colon and 
rectum. A total of 6 patients who were unable to undergo total 
ileocolonoscopy due to incomplete preparation or unbearable 
pain were excluded from the study. In addition, two patients 
with inadequate imaging information following ileocolonos-
copy were excluded (Fig. 1). Demographic information, details 
on the hematological condition, symptoms and histological 
findings were retrospectively obtained from the patients' 
medical records. All study participants provided informed 
consent. The study was approved by the local ethics review 
committee (approval no. 1610-013) and was registered at the 
University Hospital Medical Network Clinical Trials Registry 
(UMIN-CTR; registration no. UMIN000025390).
Endoscopic protocol. Experienced endoscopists performed 
the ileocolonoscopy in all patients using Olympus endoscopes 
(CF-H260I, CF-Q260I, PCF-Q260AI, CF-HQ-290I, CF-H290I 
or PCF-290I; Olympus Optical). Ileocolonoscopic images were 
evaluated based on the presence of villous atrophy observed in 
the terminal ileum (Figs. 2 and 3). Regarding the preparation 
for ileocolonoscopy, all patients were administered polyeth-
ylene glycol (PEG) if oral ingestion was possible.
A total of 3 experienced endoscopists (>10 years as a gastro-
enterologist) from multiple institutions (Okayama University, 
Kagawa Prefectural Central Hospital, and Hiroshima Citizens 
Hospital) served as observers (A,B,C) and examined the 
images for the presence of villous atrophy in the terminal 
ileum. They were blinded to any patient information, including 
pathological diagnosis of GVHD, during the determination of 
atrophy. The 3 endoscopists were blindly evaluated to check 
for inter- and intra-observer agreement.
Pathological examination. Biopsy specimens from all patients 
were subjected to routine HE staining for pathological examina-
tion. The pathological diagnosis of GVHD was based on the 
following criteria: i) The presence of apoptotic bodies in the 
epithelium of the ileum, colon or rectum; ii) crypt abnormalities 
of degeneration, dilatation, abscesses or loss; iii) all histological 
findings were determined by HE staining and CD8 immunos-
taining (Fig. 4). In the present study, GVHD was diagnosed when 
all of these three previously listed criteria were met. The gold 
standard of GVHD diagnosis is positive pathological detection. 
A patient was diagnosed with GVHD if the pathological find-
ings of any ileocolonoscopic samples met these criteria.
Statistical analysis. All analyses were performed using 
JMP version 11.2 (StataCorp). Statistical comparisons were 
performed using the Student's t-test. P<0.05 was considered 
to indicate statistical significance. Reproducibility coefficients 
were analyzed using the kappa agreement coefficient. Intra‑ 
and inter‑observer agreement values were classified as follows: 
Poor (≤0.20), slight (0.21‑0.40), moderate (0.41‑0.60), substan-
tial (0.61-0.80) and excellent (0.81-1.00). Diagnostic values, 
the diagnostic value of the ileocolonoscopy observation result 
compared with the pathological result as a gold standard, were 
compared among observers and for each observer in terms 
of sensitivity, specificity, positive predictive value (PPV) and 
negative predictive value (NPV) by a 2x2 contingency table 
using the Student's t-test.
Results
Patient demographics. The characteristics of the 54 patients are 
presented in Table I. Definitive pathological and non‑patholog-
ical GVHDs were identified in 22 and 32 patients, respectively. 
The mean patient age was 46 years and the youngest patient 
was aged 10 years (range, 10-67) years. The most common 
diagnosis was acute myeloid leukemia.
The results of examining whether villous atrophy could 
predict GVHD in all 54 sets of images were as follows. The 
sensitivity (which examines whether villous atrophy could 
predict GVHD) was 86.4, 77.3 and 79.2%, respectively, and 
the specificity was 62.5, 62.5 and 86.7%, respectively, for the 
three observers (A, B and C). Furthermore, the PPV was 61.3, 
58.6 and 82.6%, respectively, whereas the NPV was 87.0, 80.0 
and 83.9%, respectively (Tables II-IV).
Inter‑observer agreement. Table V displays the inter-observer 
reliability of each observer. Kappa coefficients among 
observers A and B, A and C and B and C were 0.85, 0.63 and 
0.63, respectively (Table V).
Intra‑observer agreement. When analyzing the villous 
atrophy in all patients, the intra‑observer kappa coefficient was 
determined to be 0.88 (95% CI 0.83-0.94) for observer A, 0.73 
(95% CI 0.65-0.81) for observer B and 0.75 (95% CI 0.70-0.81) 
for observer C (Table IV).
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Discussion
The present study was the first, to the best of our knowledge, 
to investigate the inter- and intra-observer agreement for the 
ileocolonoscopic finding of villous atrophy in the terminal 
ileum to detect acute intestinal GVHD in multiple institutions.
A previous study by our group suggested that villous 
atrophy in the terminal ileum is a useful endoscopic finding 
in acute intestinal GVHD (6). Of note, the pathological diag-
nosis is indispensable for the final diagnosis of acute intestinal 
GVHD; however, the study by our group reported that villous 
atrophy in the terminal ileum is an important indicator for 
the estimation using ileocolonoscopy. Comparing this finding 
and the diagnosis of acute intestinal GVHD, the sensitivity of 
villous atrophy observed in the terminal ileum was 86.4, 77.3 
and 79.2%, whereas the specificity was 62.5, 62.5 and 86.7%, 
for observers A, B and C, respectively. In a previous study, 
Altun et al (7) reported that lower endoscopic findings had a 
sensitivity and specificity of 40 and 0%, respectively. However, 
this study only examined a low number of patients in only one 
facility and did not emphasize the importance of terminal 
ileum observation. According to the previous study by our 
group, villous atrophy in the terminal ileum is an important 
finding (6); therefore, the terminal ileum should be visualized 
during colonoscopy.
To the best of our knowledge, the present study was the 
first to examine the inter‑observer agreement of ileocolono-
scopic findings for predicting GVHD. The kappa value for 
inter-observer agreement was 0.85 for observers A and B, 0.63 
for A and C, and 0.63 for B and C. Based on these results, 
the inter-observer agreement was substantial to excellent in 
Figure 1. Flow diagram of the study. GVHD, graft-vs.-host disease; 
allo-HSCT, allo-hematopoietic stem cell transplantation.
Figure 2. Endoscopic images with villous atrophy at the terminal ileum. Images 
are from the same patient pathologically diagnosed with GVHD. Villous 
atrophy was determined to be present when it was not possible to confirm villus 
contours at the terminal ileum using white light or indigo carmine images.
Figure 3. Endoscopic images without villus atrophy at the terminal ileum. 
Images are from the same patient who was not pathologically diagnosed with 
GVHD. Villous atrophy was determined to be absent when villous outlines 
were confirmed by white light or indigo carmine images at the end of the ileum.
Figure 4. Pathological examination. (A) Histological observation of apoptotic 
bodies in the epithelial ileum (black arrows). (B) Cells positive for CD8 on 
immunostaining observed in the abnormal crypt with abscess formation 
(black arrows). Magnification, x400.
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clinical practice. If an endoscopist has a certain amount of 
clinical experience, villous atrophy in the terminal ileum may 
be considered to have an excellent inter-observer agreement, 
even if the observers are from different institutions.
Certain endoscopists may argue that complete ileocolonos-
copy, which requires insertion into the terminal ileum, is not 
widely accepted, as it is completely invasive and associated with 
a high risk of complications (8). However, we believe that careful 
endoscopic insertion techniques will enable rapid endoscopic 
diagnosis of acute intestinal GVHD. It may be speculated that 
pathological examination of acute intestinal GVHD is required 
for the diagnosis; however, endoscopic evaluation is also 
important, as the results may be obtained faster compared with 
pathological examination. In a previous study, endoscopic and 
histological findings of distal colonoscopy were indicated to be 
Table IV. Association between the number of patients with 
GVHD and villous atrophy by Observer C.
 GVHD
 ------------------------------------------------
Villous atrophy Positive Negative Total
Positive 19 4 23
Negative 5 26 31
Total 24 30 54
Sensitivity, 79.2%; specificity, 86.7%; positive predictive value, 82.6%; 
negative predictive value, 83.9%. GVHD, graft-vs.-host disease.
Table V. Parameters of intraobserver and interobserver agree-
ment regarding villous atrophy.
A, Inter‑observer agreement (Kappa coefficient)
Observer A B C
A 1 0.85 0.63
B 1 0.63 
C 1 
B, Intra-observer agreement  
Observer A B C
Kappa value 0.88 0.73 0.75
95% CI  0.83-0.94 0.65-0.81 0.70-0.81
Table I. Characteristics of patients suspected to have gastroin-
testinal GVHD who underwent colonoscopy.
Item Value
Pathological result  
  GVHD 22
  No GVHD  32
Age (years), mean (range) 46 (10-67)
Sex 
  Male 32
  Female 22
Disease requiring transplantation 
  Acute myeloid leukaemia  15
  Myelodysplastic syndromes 11
  Acute lymphoblastic leukaemia  8
  Adult T-cell leukemia/lymphoma 4
  T lymphoblastic leukemia/lymphoma 4
  B lymphoblastic leukemia/lymphoma 3
  Chronic myelogenous leukaemia  3
  Diffuse large B-cell lymphoma 1
  Myelofibrosis 1
  Non-Hodgkin lymphoma 1
  Extranodal NK/T-cell lymphoma 1
  Polycythaemia 1
  Severe combined immunodeficiency 1
Stem cell source 
  Bone marrow 39
  Cord blood 9
  Peripheral blood stem cell 6
n=54. Values are expressed as n unless otherwise specified. GVHD, 
graft-vs.-host disease; NK, natural killer.
Table II. Association between the number of patients with 
GVHD and villous atrophy by Observer A.
 GVHD
 ------------------------------------------------
Villous atrophy Positive Negative Total
Positive 19 12 31
Negative 3 20 23
Total 22 32 54 
Sensitivity, 86.4%; specificity, 62.5%; positive predictive value, 61.3%; 
negative predictive value, 87.2%. GVHD, graft-vs.-host disease.
Table III. Association between the number of patients with 
GVHD and villous atrophy by Observer B.
 GVHD
 ------------------------------------------------
Villous atrophy Positive Negative Total
Positive 17 12 29
Negative 5 20 25
Total 22 32 54 
Sensitivity, 77.3%; specificity, 62.5%; positive predictive value, 58.6%; 
negative predictive value, 80.0%. GVHD, graft-vs.-host disease.
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clinically signifi cant in diagnosing patients who had intestinal 
GVHD with a poor general condition and who were at high 
risk of developing endoscopy-associated complications (9). 
Depending on the patient's condition, it is possible to prepare 
a testable condition by carefully prepping patients with PEG 
and enema. The method is to reduce the amount of food taken 
by patients and taking PEG on the day before the examination. 
On the day of examination, patients should take PEG carefully 
while paying attention to their symptoms. Prepping of patients 
is complete when the patient has taken ~2,000 ml of PEG and 
solid excretion has almost disappeared. Enema is performed if 
patients are not adequately prepped before examination
The present study had several limitations. First, since it 
was a retrospective study, images of the terminal ileum were 
already acquired. The location and angle of images were 
different for each endoscopist, which may have had an infl uence 
on the results of the present study. Furthermore, only 54 cases 
were screened by three observers, and it was not evaluated 
whether this number of patients and the number of observers 
were appropriate. Finally, the present study does not consider 
GVHD with cytomegalovirus or thrombotic microangiopathy. 
To the best of our knowledge, no studies have been performed 
on how the mucosa at the terminal ileum changes in GVHD 
with the above diseases. The study on the ileal mucosa of these 
diseases is an important theme for the future.
In conclusion, substantial inter- and intra-observer agree-
ment was achieved for the detection of villous atrophy in the 
terminal ileum and the inter-observer agreement for the predic-
tive histological diagnosis was also substantial to excellent, 
whereas the intra-observer agreement ranged from substantial 
to excellent for villous atrophy in the terminal ileum and acute 
intestinal GVHD. Based on the results of the present study, 
villous atrophy in the terminal ileum was a clinically effec-
tive diagnostic parameter even if different endoscopists from 
multiple institutions were involved in the diagnosis.
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